YM155 induces alterations in two pathways – triggering the ER stress/UPR and selectively abrogating STAT3-dependent transcription factor activity – that seem to ultimately result in a depletion of the anti-apoptotic protein Mcl-1 in MM cells. The gene discussed is STAT3; the disease is Miyoshi myopathy.